Delivery Order SPE2DB22D1202-SPE2DB25FVHW6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,665.23 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Trelegy Ellipta 100-62.5-25, a combination inhalation powder used in the treatment of chronic obstructive pulmonary disease. This non-competitive delivery order represents a firm fixed price transaction with a completion date of August 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,920.61 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The award, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a firm fixed price delivery order with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $14,019.75 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used in the treatment of chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order was issued on August 21, 2025, with an ultimate completion date of August 22, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $23,885.70 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trelegy Ellipta 100-62.5-25, a combination inhalation powder used to treat chronic obstructive pulmonary disease. This non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 8, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for pharmaceutical supplies valued at $2,186.63. The order is for Trelegy Ellipta 200-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease, with an ultimate completion date of July 24, 2025. This firm fixed price delivery order represents a non-competitive award utilizing AmerisourceBergen's existing contract vehicle and reflects the...
- The Defense Logistics Agency awarded a delivery order valued at $3,850.74 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in the treatment of chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order was issued on July 31, 2025, with an ultimate completion date of August 1, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $26,582.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation medication used to treat chronic obstructive pulmonary disease. The contract was competitively awarded with no set-aside designation and is set for completion by August 4, 2025. This delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,671.43 to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder in a 60-dose configuration. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of August 22, 2025. The award is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,435.33 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 60S, a combination inhalation medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-competitive set-aside procurement executed through AmerisourceBergen's existing contract vehicle with the DLA. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Trelegy Ellipta 100-62.5-25 (a combination inhaler medication for chronic obstructive pulmonary disease treatment). This competitively awarded, non-set-aside contract carries a ceiling value of $13,468.45 and is structured as a firm fixed price delivery order with an ultimate completion date of August 1, 2025. The work will be performed at AmerisourceBergen's Corporate...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVHW6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $34,728.79 to AmerisourceBergen Drug Corp for the supply of Trelegy Ellipta 100-62.5-25, a combination inhalation powder medication used primarily for chronic obstructive pulmonary disease management. This firm fixed-price delivery order, with an ultimate completion date of August 21, 2025, was awarded on August 20, 2025, through competitive procedures with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child order under a larger vehicle supporting federal pharmaceutical procurement. This delivery order falls under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs and other federal health systems worldwide. AmerisourceBergen, as a major pharmaceutical distributor and critical vendor for federal medical procurement, has demonstrated capability to meet DLA requirements through open competition across a diverse portfolio of therapeutic domains and order values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.7k | 8/20/25 |